R3i

WHO WE ARE

r3i Ventures is a woman founded early stage venture fund, dedicated to investing in women founders that disrupt and deliver impact. For example through its investments in StratifiCare, a company delivering the world’s first severe dengue prognostic to the global market. As a spinoff from the National University of Singapore, our Women Cofounders are working hard to improve patient outcomes, through delivering the right information at the right time, ensuring beds are made available only to those at risk severe dengue patients in need, and reducing the financial burden of unnecessary hospitalization by 67% on women and their families.

TARGET SIZE OF FUNDS

Sector

Tech-Agnostic, Disruptive Tech, Biotech, Fintech, Marketplace Apps

Stage

Seed, Series A, Pre-Seed

Region

Asia, Europe

Countries

Singapore, Australia, US

Founder(s)

Leesa Soulodre

As a Xennial, born with an analog childhood, and digital adulthood, Leesa Soulodre is a serial entrepreneur who has invested her lifetime on the frontiers of DeepTech pioneering, digital transformation and innovation. She has served more than 400+ multinationals and a plethora of start-ups in 19 sectors across Europe, the Asia-Pacific, and the Americas.